Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta adrenergic blocking agents for exertional angina pectoris.

U Thadani

    Herz
    |June 1, 1982
    PubMed
    Summary

    Beta adrenergic blocking agents effectively manage exertional angina by blocking beta 1 receptors, reducing anginal attacks. All equipotent beta blockers demonstrate equal antianginal efficacy, though potential side effects like heart failure and bronchospasm exist.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, angina, and heart failure.

    Heart disease (Hagerstown, Md.)·2001
    Same author

    Treatment of stable angina.

    Current opinion in cardiology·1999
    Same author

    Supersensitivity to serotonin- and histamine-induced arterial contraction following ovariectomy.

    European journal of pharmacology·1998
    Same author

    Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction: a double-blind, randomized angiographic trial of lanoteplase versus alteplase.

    Circulation·1998
    Same author

    Choosing the most appropriate treatment for stable angina. Safety considerations.

    Drug safety·1998
    Same author

    FDA Panel report: January 1998.

    Circulation·1998

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Stable exertional angina pectoris significantly impacts patient quality of life.
    • Beta adrenergic blocking agents are a cornerstone in managing anginal symptoms.

    Purpose of the Study:

    • To evaluate the efficacy of beta adrenergic blocking agents in stable exertional angina.
    • To compare the antianginal effectiveness of beta blockers with varying pharmacological properties.

    Main Methods:

    • Review of comparative studies involving beta adrenergic blocking agents.
    • Analysis of different administration routes (intravenous, oral) and durations of therapy.
    • Assessment of equipotent dosing across various beta blockers.

    Main Results:

    • Beta blockers reduce anginal attack frequency, nitroglycerin use, and improve exercise tolerance.
    • Efficacy is primarily attributed to beta 1 receptor blockade, mitigating sympathetic effects on myocardial oxygen demand.
    • All equipotent beta adrenergic blocking agents demonstrate comparable antianginal effectiveness, irrespective of ancillary properties like ISA or cardioselectivity.

    Conclusions:

    • Beta adrenergic blocking agents are equally effective for stable exertional angina when administered in equipotent doses.
    • Potential risks include precipitating heart failure or worsening bronchospasm in susceptible individuals.
    • Ancillary properties are less critical to antianginal efficacy than beta 1 receptor blockade.

    Related Experiment Videos